MICHAEL S WYZGA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL S WYZGA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL S WYZGA. MICHAEL S WYZGA is Director in EXACT SCIENCES CORP ($EXAS) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Director in X4 Pharmaceuticals, Inc ($ASNS) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in LogicBio Therapeutics, Inc. ($LOGC).
Latest Insider Trading Transactions of MICHAEL S WYZGA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, EXAS, LOGC, OMED, ASNS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | M | 0.00 | 3,141 | 0 | 0 | |
| Jan 04 2021 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Buy | M | 0.00 | 3,141 | 0 | 3,141 | 0 to 3.1 K |
| Jul 24 2020 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 2,558 | 0 | 11,471 | 8.9 K to 11.5 K (+28.70 %) |
| Jun 23 2020 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 0.00 | 3,141 | 0 | 3,141 | |
| Jun 23 2020 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 7.96 | 10,000 | 79,600 | 10,000 | |
| Jun 11 2020 | ASNS | X4 Pharmaceuticals ... | WYZGA MICHAEL S | Director | Option Exercise | A | 8.69 | 3,427 | 29,781 | 3,427 | |
| Dec 20 2019 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 12.65 | 10,869 | 137,493 | 10,869 | |
| Aug 02 2019 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Option Exercise | M | 26.98 | 2,500 | 67,450 | 10,108 | |
| Aug 02 2019 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Sell | S | 117.93 | 5,000 | 589,650 | 8,913 | 13.9 K to 8.9 K (-35.94 %) |
| Aug 02 2019 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Buy | M | 26.98 | 2,500 | 67,450 | 13,913 | 11.4 K to 13.9 K (+21.90 %) |
| Jul 26 2019 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 2,801 | 0 | 11,413 | 8.6 K to 11.4 K (+32.52 %) |
| Mar 14 2019 | ASNS | X4 Pharmaceuticals ... | WYZGA MICHAEL S | Director | Option Exercise | A | 10.44 | 70,324 | 734,183 | 70,324 | |
| Mar 14 2019 | ASNS | X4 Pharmaceuticals ... | WYZGA MICHAEL S | Director | Option Exercise | A | 10.44 | 70,324 | 734,183 | 70,324 | |
| Mar 01 2019 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Sell | S | 96.00 | 500 | 48,000 | 8,612 | 9.1 K to 8.6 K (-5.49 %) |
| Oct 22 2018 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 10.00 | 24,102 | 241,020 | 24,102 | |
| Oct 22 2018 | LOGC | LogicBio Therapeut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 10.00 | 24,102 | 241,020 | 24,102 | |
| Aug 30 2018 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Sell | S | 74.85 | 2,468 | 184,730 | 9,112 | 11.6 K to 9.1 K (-21.31 %) |
| Jul 30 2018 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Option Exercise | A | 0.00 | 3,230 | 0 | 3,230 | |
| Jul 30 2018 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 606 | 0 | 11,580 | 11 K to 11.6 K (+5.52 %) |
| Jun 25 2018 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 2.55 | 15,000 | 38,250 | 15,000 | |
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | WYZGA MICHAEL S | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| May 11 2018 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Sell | S | 51.53 | 7,402 | 381,447 | 10,974 | 18.4 K to 11 K (-40.28 %) |
| Jul 31 2017 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Option Exercise | A | 0.00 | 5,273 | 0 | 5,273 | |
| Jul 31 2017 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 791 | 0 | 18,376 | 17.6 K to 18.4 K (+4.50 %) |
| Jun 19 2017 | AKBA | Akebia Therapeutic ... | WYZGA MICHAEL S | Option Exercise | A | 14.37 | 12,500 | 179,625 | 12,500 | ||
| Jun 02 2017 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 3.30 | 15,000 | 49,500 | 15,000 | |
| Aug 01 2016 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 11,547 | 0 | 17,585 | 6 K to 17.6 K (+191.24 %) |
| Aug 01 2016 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 11,547 | 0 | 17,585 | 6 K to 17.6 K (+191.24 %) |
| Jun 24 2016 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 12.61 | 15,000 | 189,150 | 15,000 | |
| Jun 20 2016 | AKBA | Akebia Therapeutic ... | WYZGA MICHAEL S | Option Exercise | A | 8.56 | 12,500 | 107,000 | 12,500 | ||
| Jul 27 2015 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Option Exercise | A | 0.00 | 7,984 | 0 | 7,984 | |
| Jul 27 2015 | EXAS | EXACT SCIENCES COR ... | WYZGA MICHAEL S | Director | Grant | A | 0.00 | 6,038 | 0 | 6,038 | 0 to 6 K |
| Jun 23 2015 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 25.45 | 15,000 | 381,750 | 15,000 | |
| Jun 12 2015 | AKBA | Akebia Therapeutic ... | WYZGA MICHAEL S | Director | Option Exercise | A | 7.86 | 5,000 | 39,300 | 5,000 |
Page: 1